DAFTAR PUSTAKA

American Joint Committee (2009). Diakses 21 Maret, 2016, from

https://cancerstaging.org/references-
tools/quickreferences/Documents/BreastMedium.pdf.

((RSKD), R. (2002). Pentalaksanaan Kanker Payudara Terkini/Tim

Penanggulangan & Pelayanan Kanker Payudara Terpadu Paripurna (1st
ed., Vol. I). Jakarta: Pustaka Populer Obor.
American Joint Committee on Cancer 7th. (2010). Breast Cancer Staging 7th ed.
Retrieved April 2, 2016, from https://cancerstaging.org/references-
tools/quickreferences/Documents/BreastMedium.pdf
Aryandono. (2006). Semakin Tinggi Penderita Kanker Payudara di Usia Muda.
Retrieved Maret 20, 2016, from http://ugm.ac.id/id/berita/1811-
semakin.tinggi.penderita.kanker.payudara.di.usia.muda
Ayadi, L., & Khabir, A. (2008). Correlation of HER-2 over-expression with
clinico-pathological parameters in Tunisian Breast Carcinoma, 112.
Retrieved from http://www.wjso.com
Cho, H. S., Mason, K., Ramyar, K. X., Stanley, A. M., Gabelli, S. B., Denney, D.
W. Jr., et al. (2003). Structure of the extracelullar region of HER2 alone
and in complex with the Herceptin Fab. Nature 421, 756-760.
CL, C., & LC, C. (2005). Molecular Targets in Oncology: Signal Transduction
System (VII ed.). Lippincot-Raven.
Committee, A. J. (2009). Retrieved Maret 21, 2016, from
https://cancerstaging.org/references-
tools/quickreferences/Documents/BreastMedium.pdf.
DiLeo., D. M.-L. (2002). Current status of HER-2 testing, 25-32.
Fan, Y. X., Wong, L., Ding, J., Spiridonov, N. A., Johnson, R. C., & Johnson, G.
R. (2008). Mutational activation of ErbB2 reveals a new protein kinase
autoinhibition mechanism. J. Biol. Chem. 283, 1588-1596.
Gautam K. Malhotra, X. Z. (2010). Histological, Molecular and Functional
Subtypes. 956.
Globocan. (2012). Cancer Fact Sheets. Retrieved Maret 20, 2016, from
http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx

48
 49

GLOBOCAN. (2012). International Agency for Reasearch on Cancer. Retrieved

March 23, 2015, from GLOBOCAN 2012 IARC:
http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx
Gray, M., & Gallick, G. (2010). The role of oncogene activation in tumor
progression, 19-22.
Greulich, H., Kaplan, B., Mertins, P., Chen, T. H., Tanaka, K. E., Yun, C. H., et
al. (2012). Functional analysis of receptor tyrosine kinase mutations in
lung cancer identifies oncogenic extracellular domain mutations of
ERBB2. Proc. Natl. Acad. Sci. U. S. A. 109, 14476-14481.
Grushko, T., & Olopaeda, O. (2008). Genetic Markers in Breast Tumors With
Hereditary Predisposition, 85-93.
Harris, L., Fritsche, H., & Mennel, R. (2007). Journal of Clinical Oncology.
Update of Recommendation for the Use of Tumor Marker in Breast
Cancer, 25. Retrieved April 4, 2016, from http://www.jco.ascopubs.org
Institute, N. C. (2015). What is cancer ? Retrieved Maret 20, 2016, from
http://www.cancer.gov/cancertopics/what-is-cancer.
Junquera, L., & Carneiro, J. (2007). Histologi Dasar Teks dan Atlas (10th ed.).
Jakarta: EGC.
Kamarlis, R. K. (2009). Tampilan Imunohistokimia HER-2/neu Pada Biopsi
Aspirasi Jarum Halus Penderita Kanker Payudara, 45-48.
KPKN, K. (2015). Panduan Nasional Pembangunan Kanker Payudara. Retrieved
Maret 20, 2016, from
https://kanker.kemkes.go.id/guidelines/PPKPayudara.pdf
Kresna, S. B. (2014). Biomarker Keganasan (1st ed.). Jakarta: Badan Penerbit
FKUI.
Kumar, V. A. (2015). Robbins and Kontran Pathologic Basic of Disease (9th ed.).
Philadelphia: Elsevier Saunders.
Lee, J. W., Soung, Y. H., Seo, S. H., Kim, S. Y., Park, C. H., Wang, Y. P., et al.
(2006). Somatic mutations of ERBB2 kinase domain in gastric, colorectal,
and breast carcinomas. Clin. Cancer Res. 12, 57-61
Lina, M. (2004). Kanker pada Wanita: Pencegahan dan Pengobatan dengan
Tanaman Obat. Jakarta: Penebar Swadaya.
Maimun, M. (2013). Payudarapedia. Retrieved from Anatomi dan Fisiologi
Payudara: http://payudarapedia.blogspot.co.id/2013/05/anatomi-dan-
fisiologi-payudara.html
 50

Mane, A. (2015). A Comparison of Clinical Features, Pathology and Outcomes in

Various Subtypes of Breast Cancer in Indian Woman, 1.
Mary, C., & Lori J., G. (2016). Prognostic and Predictive Factors in Early-Stage
Breast Cancer. Retrieved April 4, 2016, from
http://theoncologist.alphamedpress.org/content/9/6/606.full
Moonkhouse, S. (2007). Clinical Anatomy (2nd ed.). China: Churchill Livingstone
Elsevier.
Notoatmodjo, S. (2010). Metodologi Penelitian Kesehatan. Jakarta: Rineka Cipta.
NPD, W. (2014). In Situ Hybridization pada Kanker Payudara. Retrieved from
http://journal.uii.ac.id/index.php/JKKI/article/view/3392/3041
Otto, S. (2001). Oncology Nursing (4th ed.). Mosby years book.
Payne, S., Bowen, R., Jones, J., & Wells, C. (2008). Predictive Marker in Breast
Cancer The Present, 82-90.
Pedersen, K., Angelini, P. D., Laos, S., Bach-Faig, A., Cunningham, M. P.,
Ferrer-Ramon, C., et al. (2009). A naturally occuring HER2 carboxy-
terminal fragment promotes mammary tumor growth and metastasis. Mol.
Cell. Biol. 29, 3319-3331.
Price, S., & Wilson, L. (2005). Patofisiologi Konsep Klinis Proses-Proses
Penyakit. Jakarta: EGC.
Pringguoutomo, S., Himawan, S., & Tjarta, A. (2002). Buku Ajar Patologi I
(UMUM) (1st ed.). Jakarta: Sagung Seto.
Rahman, A. (2014). Hubungan Ekspresi HER-2/neu dan Hormonal Reseptor
Dengan Grading Histopatologi Pada Penderita Kanker Payudara Wanita
Usia Muda.
Ramli, M., Umbas, R., & Panigoro, S. (2000). Deteksi Dini Kanker.
RI, P. D. (2015). Retrieved Maret 20, 2016, from
http://www.depkes.go.id/resources/download/pusdatin/infodatin/infodatin-
kanker.pdf.
Sabiston, A. (2011). Buku Ajar Bedah I. Jakarta: EGC.
Sastroasmoro, S., & Ismael, S. (2011). Dasar-Dasar Metodologi Penelitian Klinis
(4th ed.). Jakarta: Sagung Seto.
Sjamsuhidajat, R., & de Jong, W. (2010). Buku Ajar Ilmu Bedah. Jakarta: EGC.
Smith, S. J. (2001). Breast Cancer: Neu Oppurtinity and Neu Challenges, 213-
219.
 51

Stephens, P. H. (2004). Lung cancer: intragenic ERBB2 kinase mutations in

tumors. Nature 431, 525-526.
Tanto, C., L., F., & H., S. (2014). Kapita Selekta Kedokteran. Jakarta: Media
Aesculapius.
Tjahdadi, V. (2008). Kanker Payudara. Retrieved Maret 20, 2016, from
http://bima.ipb.ac.id/~anita/kanker_payudara.htm
UNDIP, T. K. (2006). Kanker Payudara Wanita. Ekspresi Reseptor Estrogen,
Reseptor Progesteron dan HER-2. Retrieved Maret 24, 2016, from
www.m3undip.org/ed3/artikel_t
Wahid, S., Miskad, U. A., & Djimahit, T. (2008). Ekspresi HER-2/neu pada
Kanker Payudara. Korelasi Bermakna Dengan Grading Histopatologi.
Retrieved Maret 20, 2016, from
http://www.med.unhas.ac.id/journal/dmdocuments/journal 2008.
Wan, D. (2011). Buku Ajar Onkologi Klinis (2nd ed.). Jakarta: Balai Penerbit FK
UI.
WHO. (2013). Cancer Fact Sheet. Retrieved Maret 20, 2016, from
http://www.searo.who.int/entity/noncommunicable_diseases/advocacy/can
cer_fact_sheet.pdf?ua=1.
William, H. (2004). Profil Gena HER-2/neu pada Penderita Kanker Payudara di
Makassar.
World Health Organization. (2015). World Health Organization. Retrieved March
17, 2015, from World Health Organization:
http://www.who.int/cancer/detection/breastcancer/en/